These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series. Wisely CE; Liu KC; Gupta D; Carlson AN; Asrani SG; Kim T Am J Ophthalmol; 2020 Sep; 217():20-26. PubMed ID: 32289295 [TBL] [Abstract][Full Text] [Related]
5. Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series. Moumneh K; Sheybani A; Fellman RL; Godfrey DG; Grover DS J Glaucoma; 2020 Jul; 29(7):607-610. PubMed ID: 32398584 [TBL] [Abstract][Full Text] [Related]
6. Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil: A Case Series and Review. LoBue SA; Moustafa GA; Vu A; Amin M; Nguyen T; Goyal H Cornea; 2021 Aug; 40(8):1048-1054. PubMed ID: 33369939 [TBL] [Abstract][Full Text] [Related]
8. Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil. Jeang LJ; Shah AS; Hammer JD; Tuli SS Digit J Ophthalmol; 2022; 28(8):34-37. PubMed ID: 35854963 [TBL] [Abstract][Full Text] [Related]
9. Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil. Chen H; McMillin JC; Frankfort BJ; Al-Mohtaseb Z J Glaucoma; 2020 Nov; 29(11):e124-e126. PubMed ID: 32826765 [TBL] [Abstract][Full Text] [Related]
10. Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario. Bhargava M; Sen S; Bhambhani V; Paul RS; Dutta C Indian J Ophthalmol; 2022 Apr; 70(4):1163-1170. PubMed ID: 35326007 [TBL] [Abstract][Full Text] [Related]
11. Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty. Chen SL; LoBue SA; Goyal H Am J Ophthalmol Case Rep; 2021 Jun; 22():101087. PubMed ID: 33997467 [TBL] [Abstract][Full Text] [Related]
12. Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma. Ganesh D; Coleman AL; Shibayama VP; Tseng VL Case Rep Ophthalmol; 2022; 13(2):330-335. PubMed ID: 35702654 [TBL] [Abstract][Full Text] [Related]
13. Rhopressa-induced corneal edema: a case report. Chu MJ; Song M; Palmares T; Song A; Song J J Med Case Rep; 2021 Apr; 15(1):182. PubMed ID: 33810801 [TBL] [Abstract][Full Text] [Related]
14. "Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost". Chung D; Meier EJ Am J Ophthalmol Case Rep; 2022 Jun; 26():101501. PubMed ID: 35387385 [TBL] [Abstract][Full Text] [Related]
15. Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy. Davies E; Jurkunas U; Pineda R Cornea; 2021 Jul; 40(7):899-902. PubMed ID: 33758139 [TBL] [Abstract][Full Text] [Related]
16. Case Series: Novel Utilization of Rho-Kinase Inhibitor for the Treatment of Corneal Edema. Davies E Cornea; 2021 Jan; 40(1):116-120. PubMed ID: 33269892 [TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy. Price MO; Price FW Am J Ophthalmol; 2021 Jul; 227():100-105. PubMed ID: 33737034 [TBL] [Abstract][Full Text] [Related]
19. Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension. Batra M; Gupta S; Nair AB; Dhanawat M; Sandal S; Morsy MA Eur J Ophthalmol; 2021 Sep; 31(5):2237-2244. PubMed ID: 33843288 [TBL] [Abstract][Full Text] [Related]